Background Image
Table of Contents Table of Contents
Previous Page  36 / 64 Next Page
Information
Show Menu
Previous Page 36 / 64 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 6, November/December 2020

316

AFRICA

BP, BG and TG. However, a significant gender difference

was observed for body mass index (BMI) (

p

< 0.001), hip

circumference (

p

< 0.001), waist–hip ratio (

p

< 0.001), systolic

BP (

p

< 0.001) and HDL-C (

p

< 0.001). The women presented

with a higher BMI (34.4 vs 13.0%) and WC (45.5 vs 11.0%) and

a lower HDL-C (50.0 vs 48.7%) compared to the men, who

presented with a higher systolic BP (50.3 vs 39.4%).

The overall prevalence of AO as determined by WC was

estimated at 47.9%, resulting in an estimated prevalence of the

MetS of 32.7% (IDF).

9

The prevalence of AO and the MetS was

found to be higher among women, at 69 vs 24.5% (

p

= 0.05), than

men, at 44.5 vs 20.0% (

p

= 0.001) (Table 1). Overall, low HDL-C

identified the highest candidates for the MetS (49.4%), followed

by WC (47.9%), TG (47.4%) and elevated BP (44.7%) (Table 1).

The ROC curve was used to determine the optimal cut-off

points for AO, predicting at least two other indicators for the

MetS in both genders. For men, the ability of WC to predict

at least two other indicators of the MetS revealed a sensitivity

of 69.1% and specificity of 90.8%, and AUC of 0.85, giving a

cut-off point of ≥ 91.0 cm (Fig. 1). Furthermore, the AUC for

the women was 0.76, with a sensitivity of 88.6% and specificity

of 58.9%, yielding a cut-off point of ≥ 82.3 cm (Fig. 2).

The prevalence of AO, as determined by the two cut-off

values of the IDF and the current study, was similar at 47.9

and 47.4%. Differences in the prevalence were observed when

the data were further analysed according to gender. When the

prevalence of AO was defined by the IDF cut-off values, there

was a 5.8% increase in the prevalence of AO among men (from

24.5 to 30.3% when using the new cut-off values) and a 4.6%

increase in the prevalence of the MetS (from 19.9 to 24.5% using

the new cut-off values) (Table 2). For the women there was a

6.3% decrease in the prevalence of AO (69.6 to 63.3% using the

new cut-off values) and a 3.0% decrease in the prevalence of the

MetS (from 44.5 to 41.5% using the new cut-off values) (Table 2).

Discussion

The results from this survey indicate a difference between the WC

cut-off points used for Europeans for determining AO and the

currently determined cut-off points for Batswana adults (≥ 94 cm

vs ≥ 91 cm for men and ≥ 80 cm vs ≥ 82 cm for women). Gender

differences became more noticeable when data were further

analysed by gender, which led to different estimated prevalences

Table 1. Participants’ characteristics by gender

Characteristic

Number

All

Men

Women

p

-value

Number (%)

800

384 (48)

416 (52)

Age (years)

743

36.1 ± 8.9

36.3 ± 9.2

35.9 ± 8.6

0.583

BMI (kg/m

2

)

797

26.2 ± 5.7

24.2 ± 4.5

27.9 ± 6.1

< 0.001

WC (cm)

794

85.1 ± 13.9

84.1 ± 13.3

86.0 ± 14.4

0.05

HC (cm)

795

104.2 ± 12.8

99.6 ± 10.5

108.5 ± 13.3

< 0.001

WHR

794

0.82 ± 0.1

0.85 ± 0.11

0.79 ± 0.11

< 0.001

Systolic BP (mmHg)

795

127.5 ± 16.9

130.4 ± 16.7

124.7 ± 16.6

< 0.001

Diastolic BP (mmHg)

795

78.8 ± 10.8

79.2 ± 11.0

78.5 ± 10.7

0.378

BMI (%)

25

BMI < 30 kg/m

2

232

29.1

15.1

31.0

< 0.001

BMI

30 kg/m

2

192

24.1

13.0

34.4

< 0.001

WC, men/women (%)

94/80 cm

380

47.9

24.5

69.6

< 0.001

102/88 cm

230

29.0

11.0

45.7

< 0.001

WHR > 1.0/0.85

106

13.4

3.7

22.6

< 0.001

Elevated BP,

130/

85 mmHg (%)

355

44.7

50.3

39.4

0.002

BG, mmol/l (%)

779

5.3 ± 1.3

5.3 ± 1.2

5.4 ± 1.5

0.201

5.6 mmol/l (%)

251

32.2

29.9

34.2

0.207

TG, mmol/l (%)

785

1.9 ± 2.4

1.8 ± 1.0

2.0 ± 1.1

0.057

1.7 mmol/l (%)

372

47.4

46.3

48.4

HDL-C

778

1.2 ± 0.4

1.1 ± 0.4

1.3 ± 0.4

< 0.001

< 1.03/1.29 mmol/l (%)

384

49.4

48.7

50.0

MetS (%)

787

32.7

20.0

44.5

< 0.001

BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist–hip ratie; BP, blood pressure; BG, blood glucose; TG, triglycerides; HDL-C,

high-density lipoprotein cholesterol; MetS, metabolic syndrome.

100-Specificity

100

80

60

40

20

0

0

20

40

60

80

100

Sensitivity

M9: Waist circumference

C1 = 0

Sensitivity: 69.1

Specificity: 90.8

Criterion: >91

Fig. 1.

ROC curve for the WC of males.